CEFTOLOZANE

DRUG3 trials

Sponsors

Hellenic Institute For The Study Of Sepsis, Assistance Publique Hopitaux De Paris, M.D. Anderson Cancer Center

Conditions

Other Infectious DiseasesSevere infectionsantibiotic therapy in Sepsis

Phase 2

Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam

CompletedNCT03485950

M.D. Anderson Cancer CenterOther Infectious Diseases

Start: 2018-05-16End: 2022-02-16Updated: 2022-03-15

Phase 3

A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE INFECTIONS (The MODIFY trial)

Active, not recruitingCTIS2022-502962-26-00

Hellenic Institute For The Study Of SepsisSevere infections

Start: 2023-09-14Target: 190Updated: 2025-11-03

BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis

Not yet recruitingCTIS2024-516849-39-01

Assistance Publique Hopitaux De Parisantibiotic therapy in Sepsis

Target: 600Updated: 2025-12-02

Related Papers

A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies

Open Forum Infectious Diseases2022-02-1413 citations